Swiss Biotech Association’s Post

Q3 Biotech Roundup: The 2024 Turnaround Faces a Pivotal Q4 As we approach a crucial Q4, several key indicators of biotech activity are showing tentative signs of improvement. While the recovery is not yet widespread, there are indications that the industry may be inching closer to a return to robust growth.

Out now - download Issue 11 of Bristows’ annual Biotech Review, crammed full of industry insights from the last year - including our review of the first seven months of the UPC. #biotech #upc

Are you attending #BIO2024 today in San Diego? If you’ll be there, make sure to pop by for our session where our Executive Biotech Advisor, Carin Canale-Theakston, will share "An Insider Look at Top Deals from 2023” at 3pm-4pm PST. The session offers valuable insights into biotech collaborations and innovations.   Looking forward to seeing old friends and making new connections at the conference today! #Biotech #InvestorRelations #LifeSciences #CorpComms #InizioEvokeComms

Big News from Avendium! We're excited to announce that Avendium will be attending the BIO International Convention from June 3-6th! This event is a major highlight in the biotechnology industry, bringing together thought leaders and innovators from across the globe. As a dedicated Quality Assurance Functional Service provider, we specialize in ensuring that life science companies meet the highest standards of quality, efficacy, and regulatory compliance. BIO 2024 is the perfect platform for us to showcase how our services can help biotech firms excel in a competitive and tightly regulated environment. Our team is looking forward to discussing how we can support your projects with our comprehensive QA solutions. Whether you're looking to enhance your product's market readiness or ensure regulatory compliance, we have the expertise to assist you. Join us to learn more about our services and how we can help drive success in your operations. Let’s advance the future of biotechnology together! #BIO2024 #QualityAssurance #Biotechnology #LifeSciences #RegulatoryCompliance #Innovation

Developing a revolutionary biotech product is just the first step. But do you have the commercialization strategy to take it to the next level? Join our exclusive Better Biotech Growth webinar series, where we explore the key steps for turning biotech innovations into market success. Don’t miss the first session — Register today and get ahead of the curve: skp.link/iv25 #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth

Less than a week until #ISPE #Biotech - come chat with me about your #MSAT, #QRM, #QMS, or #Microbiology consulting needs!

In 1 month, biopharma leaders, regulators, investors and scientists will gather at the FT Live US Pharma and Biotech Summit @endpoints news Join the Summit to learn how the new market cycle will finance the next period of investing in innovation, debate the dueling approaches to the US life expectancy crisis and hear how artificial intelligence is splitting into two technological camps. Save 20% on your in-person or digital pass with discount code NYBIO https://bit.ly/49lvk2X #FTPharma

🔬✨ Could Soligenix (SNGX) be the next big winner in biotech? 🤔 In our latest video, we dive deep into their groundbreaking HyBryte study and explore the future potential of this innovative biopharma company. 🚀💡 Discover Soligenix's recent achievements, upcoming milestones, and why HyBryte stands out as a promising treatment in the biotech landscape. 🌟🔍 Join us as we analyze the key factors that could drive Soligenix's growth and find out if SNGX stock is a smart investment for the future. 📈💰 Watch now to get the inside scoop! 🎥 https://lnkd.in/dHArNM8R

Collaborations like this are a prime example of how Pearland connects our companies to education partners to address there needs. Check out the full article below!

Developing a revolutionary biotech product is just the first step. But do you have the commercialization strategy to take it to the next level? Join our exclusive Better Biotech Growth webinar series, where we explore the key steps for turning biotech innovations into market success. Don’t miss the first session — Register today and get ahead of the curve: skp.link/iv25 #BetterBiotechGrowth #Biotech #CommercialExcellence #SimonKucher #BiotechGrowth